Form 4: Outset Medical Director Karen Drexler Converts Preferred Stock to Common Stock
SEC Form 4 Filing
Director Karen Drexler converted Series A Non-Voting Convertible Preferred Stock into Common Stock of Outset Medical, Inc. following stockholder approval.
Summary
- Karen Drexler, a director of Outset Medical, Inc., converted Series A Non-Voting Convertible Preferred Stock into Common Stock on March 10, 2025.
- The conversion occurred after the Issuer's stockholders approved the conversion at a meeting held on March 5, 2025.
- Each share of Preferred Stock automatically converted into 250 shares of Common Stock.
- Drexler directly owns 48,232 shares of Common Stock.
- Drexler indirectly owns 31,250 shares of Common Stock through the Drexler Family Trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a stock conversion, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect broader industry trends.
Stakeholder Impact
- The conversion of preferred stock to common stock may have a slight dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Meeting of Stockholders where the conversion of Preferred Stock into Common Stock was approved. |
| 03/07/2025 | Date of transaction where Series A Non-Voting Convertible Preferred was acquired. |
| 03/10/2025 | Date of conversion of Preferred Stock into Common Stock. |
| 03/11/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.